Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00758771 · ClinicalTrials.gov registry record
Using Rheological Methods to Characterize Cystic Fibrosis (CF) Sputum and the Effects of Mucoactive Agents
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 38
- Enrollment target
NCT00758771 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 38 participants.
The verdict
NCT00758771 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 38 participants
- Enrollment target
Study Summary
The purpose of this study is to characterize the rheological properties of cystic fibrosis (CF) and healthy sputum and to examine the effects of mucoactive agents on the rheology of CF and healthy sputum. By collaborating with Genentech, the investigators (scientists at UCSF) plan to incorporate the latest scientific findings into our work to discover and develop new treatments for CF.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2007-10 |
| Est. Completion | 2012-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00758771
The ClinicalTrials.gov registry entry for NCT00758771 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00758771 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00758771 about?
NCT00758771 is a clinical study titled "Using Rheological Methods to Characterize Cystic Fibrosis (CF) Sputum and the Effects of Mucoactive Agents". The purpose of this study is to characterize the rheological properties of cystic fibrosis (CF) and healthy sputum and to examine the effects of mucoactive agents on the rheology of CF and healthy sputum. By collaborating with Genentech, the investigators (scientists at UCSF) plan to incorporate the...
What is the current status of trial NCT00758771?
This trial is currently completed. The enrollment target is 38 participants. The study started on 2007-10. Estimated completion is 2012-12.
Who is sponsoring clinical trial NCT00758771?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.